"I think first and foremost, the most exciting part is the ability to build a women's health-focused company and to be the only one doing it, to be the most focused company on women's health, which is an area that it is about time," Organon managing director Nirelle Tolstoshev told BioPharmaDispatch. …
The 'new' Organon springs to life after MSD spinout
June 3, 2021 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
'Patients can’t wait – swift action and access are the only possible moves from here'
August 26, 2025 - - Latest News -
Vaxxas secures $90 million in funding to commercialise needle-free vaccination delivery technology
August 25, 2025 - - Australian Biotech -
Bayer partners with Arrotex to strengthen access to oral contraceptives
August 25, 2025 - - Latest News -
The next negotiation was always going to be complicated, the new reality will make it more so
August 25, 2025 - - Latest News -
UK industry cites US pricing ambitions in collapse of new agreement negotiation
August 25, 2025 - - Latest News -
Botanix appoints Dr Patricia Walker as a non-executive director
August 25, 2025 - - Australian Biotech -
First site initiated for Neuren’s Phelan-McDermid syndrome Phase 3 trial
August 25, 2025 - - Australian Biotech